Fertility preservation

Mayo Clinic Proceedings

Volumn 86, Issue 1, 2011, Pages 45-49

  Jensen, Jani R ^a   Morbeck, Dean E ^a   Coddington III, Charles C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ARTICLE; AZOOSPERMIA; CANCER RADIOTHERAPY; CANCER THERAPY; CONSULTATION; CRYOPRESERVATION; GAMETE; HUMAN; INFERTILITY THERAPY; MALE INFERTILITY; OOCYTE CRYOPRESERVATION; ORGAN PRESERVATION; OVARIAN PRESERVATION; OVARIAN SUPPRESSION; OVARY INSUFFICIENCY; PREGNANCY; PROGENY; REPRODUCTION; SPERM PRESERVATION; TESTICULAR TISSUE CRYOPERSERVATION;

EID: 78650988311     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0564     Document Type: Article

References (44)

1. Altekruse S, Kosary C, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute. Based on November 2009 SEER data submission, posted to the SEER web site; 2010. Updated June 30, 2010. http://seer.cancer.gov/csr/1975-2007/index.html. Accessed October 7, 2010.
2. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer: A pilot survey of survivors' attitudes and experiences. Cancer. 1999;86(4):697-709.
3. Burns KC, Boudreau C, Panepinto JA. Attitudes regarding fertility preservation in female adolescent cancer patients. J Pediatr Hematol Oncol. 2006;28(6):350-354.
4. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917-2931.
5. Forman EJ, Anders CK, Behera MA. Pilot survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. J Reprod Med. 2009;54(4):203-207.
6. Vogel F, Rathenberg R. Spontaneous mutation in man. Adv Hum Genet. 1975;5:223-318.
7. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci. 1963;158(972):417-433.
8. Gondos B, Bhiraleus P, Hobel CJ. Ultrastructural observations on germ cells in human fetal ovaries. Am J Obstet Gynecol. 1971;110(5):644-652.
9. Himelstein-Braw R, Byskov AG, Peters H, Faber M. Follicular atresia in the infant human ovary. J Reprod Fertil. 1976;46(1):55-59.
10. Tilly JL, Niikura Y, Rueda BR. The current status of evidence for and against postnatal oogenesis in mammals: A case of ovarian optimism versus pessimism? Biol Reprod. 2009;80(1):2-12.
11. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato- oncological neoplasias and other cancers. Leuk Lymphoma. 1999;33(1-2): 65-76.
12. Goldhirsch A, Gelber RD, Castiglione M; International Breast Cancer Study Group. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. Ann Oncol. 1990;1(3):183-188.
13. da Cunha MF, Meistrich ML, Fuller LM, et al. Recovery of spermatogenesis after treatment for Hodgkin's disease: Limiting dose of MOPP chemotherapy. J Clin Oncol. 1984;2(6):571-577.
14. Heikens J, Behrendt H, Adriaanse R, Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer. 1996;78(9):2020-2024.
15. Waring AB, Wallace WH. Subfertility following treatment for childhood cancer. Hosp Med. 2000;61(8):550-557.
16. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18(1):117-121.
17. Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998;27(4):927-943.
18. Speiser B, Rubin P, Casarett G. Aspermia following lower truncal irradiation in Hodgkin's disease. Cancer. 1973;32(3):692-698.
19. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738-744.
20. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10(3):251-266.
21. Abir R, Nitke S, Ben-Haroush A, Fisch B. In vitro maturation of human primordial ovarian follicles: Clinical significance, progress in mammals, and methods for growth evaluation. Histol Histopathol. 2006;21(8):887-898.
22. Xu M, Kreeger PK, Shea LD, Woodruff TK. Tissue-engineered follicles produce live, fertile offspring. Tissue Eng. 2006;12(10):2739-2746.
23. Cowles RA, Gewanter RM, Kandel JJ. Ovarian repositioning in pediatric cancer patients: Flexible techniques accommodate pelvic radiation fields. Pediatr Blood Cancer. 2007;49(3):339-341.
24. Thibaud E, Ramirez M, Brauner R, et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr. 1992;121(6):880-884.
25. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7(6):535-543.
26. Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol. 2005;17(3):299-308.
27. Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1(8486):884-886.
28. Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte cryopreservation: New perspectives regarding oocyte survival. Hum Reprod. 2001;16(3):411-416.
29. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: A metaanalysis. Fertil Steril. 2006;86(1):70-80.
30. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18(6):769-776.
31. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol. 2005;23(16):3858-3859.
32. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91(10):3885-3890.
33. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. J Clin Oncol. 2008; 26(16):2630-2635.
34. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist. 2007;12(9):1044-1054.
35. Oktay K, Sonmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist. 2007;12(9):1055-1066.
36. Del Mastro L, Catzeddu T, Boni L, et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol. 2006;17(1):74-78.
37. Fox KR, Scialla J, Moore H. Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer [abstract 50]. Proc Am Soc Clin Oncol. 2003;22:13.
38. Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE. Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res Treat. 2008;110(3):411-416.
39. Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study. Fertil Steril. 2009;91(3):694-697.
40. Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004; 100(3):465-469.
41. Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect." Am J Obstet Gynecol. 1994;170(3):818-823.
42. von Schoultz E, Johansson H, Wilking N, Rutqvist LE. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol. 1995; 13(2):430-434.
43. Kroman N, Jensen MB, Wohlfahrt J, Ejlertsen B. Pregnancy after treatment of breast cancer: A population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol. 2008;47(4):545-549.
44. Hawkins MM. Pregnancy outcome and offspring after childhood cancer [editorial]. BMJ. 1994;309(6961):1034.